| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |